Auto-immune haematological complications occurring during the treatment of malignant lymphoproliferative diseases.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced / Q000209:etiology*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000209:etiology*
D000477:Alkylating Agents